Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials
- PMID: 16720091
- DOI: 10.1016/j.reprotox.2006.03.019
Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials
Abstract
Serotonin reuptake inhibitors (SRIs) are extensively used in management of clinical depression. Reports vary about the risk of these drugs during pregnancy. To determine the risk of exposure to SRIs, we pooled data from multiple clinical studies that investigated obstetrical outcomes in women exposed to this group of drugs during pregnancy. Studies were identified by search of PUBMED, OVID, and SCOPUS databases and the data were derived from 1990 to 2005 (August). Types of outcome investigated were spontaneous abortion, major malformations, cardiovascular malformations, and minor malformations. The criteria for inclusion of studies in this meta-analysis were exposure of women to any therapeutic dosage of SRI (citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline) during pregnancy. Our results find that SRIs do not increase the risk of major, cardiovascular and minor malformations but do increase the risk of spontaneous abortion significantly.
Similar articles
-
Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis.Daru. 2012 Nov 1;20(1):75. doi: 10.1186/2008-2231-20-75. Daru. 2012. PMID: 23351929 Free PMC article.
-
A comparative study of QT prolongation with serotonin reuptake inhibitors.Psychopharmacology (Berl). 2017 Oct;234(20):3075-3081. doi: 10.1007/s00213-017-4685-7. Epub 2017 Aug 3. Psychopharmacology (Berl). 2017. PMID: 28770276
-
A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.CNS Drugs. 2004;18(13):911-32. doi: 10.2165/00023210-200418130-00006. CNS Drugs. 2004. PMID: 15521793
-
Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review.Hum Psychopharmacol. 2007 Apr;22(3):121-8. doi: 10.1002/hup.836. Hum Psychopharmacol. 2007. PMID: 17397101 Review.
-
Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.JAMA. 2005 May 18;293(19):2372-83. doi: 10.1001/jama.293.19.2372. JAMA. 2005. PMID: 15900008 Review.
Cited by
-
Association between antidepressant use during pregnancy and miscarriage: a systematic review and meta-analysis.BMJ Open. 2024 Jan 25;14(1):e074600. doi: 10.1136/bmjopen-2023-074600. BMJ Open. 2024. PMID: 38272551 Free PMC article.
-
Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities.PLoS One. 2008 Jul 23;3(7):e2782. doi: 10.1371/journal.pone.0002782. PLoS One. 2008. PMID: 18716672 Free PMC article.
-
Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation.Indian J Psychiatry. 2015 Jul;57(Suppl 2):S354-71. doi: 10.4103/0019-5545.161504. Indian J Psychiatry. 2015. PMID: 26330654 Free PMC article. Review.
-
Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study.BMJ. 2013 Apr 19;346:f2059. doi: 10.1136/bmj.f2059. BMJ. 2013. PMID: 23604083 Free PMC article.
-
Continuing medical education: SSRIs and pregnancy.Indian J Psychiatry. 2010 Jan;52(1):83-6. doi: 10.4103/0019-5545.58906. Indian J Psychiatry. 2010. PMID: 20174529 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
